Daliresp - Roflumilast 250 ug / 1 Tablet 1 Blister Pack

Reference details for licensed healthcare facility review and verification.

roflumilast NDC Family 00310-0088 roflumilast 250 ug / 1

NDC 11	00310-0088-28
Product NDC	00310-0088
Generic Drug Name	roflumilast
Brand Name	Daliresp
Manufacturer	AstraZeneca Pharmaceuticals LP
Strength	250 ug / 1
Dosage Form	Tablet
Drug Type	Oral
Package Quantity	1 Blister Pack
Package Description	1 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-28) / 28 TABLET in 1 BLISTER PACK
Active Ingredients	Roflumilast
Marketing Category	NDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

roflumilast 250 ug / 1 Tablet is tracked under NDC 00310-0088-28 and rolls up into product family 00310-0088. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 1 Blister Pack.
Manufacturer: AstraZeneca Pharmaceuticals LP.
Dosage form: Tablet.
Family size: 2 indexed presentations.

Click a tag to refine the catalog view around this product reference.

Review the generic familyroflumilast

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Daliresp - Roflumilast 250 ug / 1 Tablet 10 Blister PackNDC 00310-0088-39 | 10 Blister Pack | AstraZeneca Pharmaceuticals LP

Daliresp - Roflumilast 250 ug / 1 Tablet 1 Blister Pack, NDC 00310-0088-28, is a AstraZeneca Pharmaceuticals LP 250 ug / 1 tablet presentation packaged as 1 Blister Pack.

NDC search formats

Canonical NDC 11: 00310-0088-28
Digits-only NDC 11: 00310008828
Possible 10-digit display formats: 0310-0088-28 (0310008828), 00310-088-28 (0031008828)

Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.

Helpful product links

Search by brand name: Daliresp
NDC 11: 00310-0088-28
Product family NDC: 00310-0088
Other package sizes in this family: 10 Blister Pack
Compare related presentations: Daliresp - Roflumilast 250 ug / 1 Tablet 10 Blister Pack
VA classification code: RE900
VA classification code description: RESPIRATORY AGENTS,OTHER
CMOP ID: R0374
VUID: 4037388